Vandana Singh
·
August 15, 2025
Benzinga
Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials.
read more
August 6, 2025
Fortune
May 17, 2025
Bloomberg
May 18, 2025